Wegovy approved to prevent heart problems or strokes in obese and overweight adults
A post-approval clinical study showed that Wegovy significantly reduced the risk of major adverse cardiovascular events by 20% compared to a placebo
The Medicines and...
Weight loss drug Semaglutide may increase risk of rare eye condition, study warns
Semaglutide is available as Ozempic for treating type 2 diabetes and as Wegovy for managing overweight and obesity
Amid the rapid rise in semaglutide usage,...
UK pharmacies cut prices for weight-loss drugs Wegovy, Mounjaro amidst escalating competition
Obesity experts raise concern that retail marketing of weight-loss drugs could trivialise their side-effects
British pharmacies and slimming clinics are reducing prices for weight-loss...
Boehringer to test obesity drug in three late-stage trials
Germany's Boehringer Ingelheim said on Thursday (Aug 17) it would conduct three late-stage studies for its obesity drug candidate after it showed up to...
Novo’s Wegovy shows heart benefit alongside weight loss in trial
Wegovy maker Novo Nordisk said on Tuesday (Aug 8) a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit,...
Weight-loss drugs pilot to begin in UK amid uncertainty over Wegovy launch
Britain plans to launch a pilot programme exploring how new weekly weight-loss shots such as Novo Nordisk's Wegovy can be given to obese patients by general...